170 related articles for article (PubMed ID: 10743281)
21. [Surveillance of secondary effects of vaccination].
Duclos P
Sante; 1994; 4(3):215-20. PubMed ID: 7921691
[TBL] [Abstract][Full Text] [Related]
22. Update: adverse events following civilian smallpox vaccination--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(34):819-20. PubMed ID: 12944880
[TBL] [Abstract][Full Text] [Related]
23. Update: adverse events following civilian smallpox vaccination--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(5):106-7. PubMed ID: 14961004
[TBL] [Abstract][Full Text] [Related]
24. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
[TBL] [Abstract][Full Text] [Related]
25. Update: Adverse events following civilian smallpox vaccination--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Apr; 52(15):343-5. PubMed ID: 12733867
[TBL] [Abstract][Full Text] [Related]
26. Use of vaccine surveillance data in the evaluation of safety of vaccines.
Postila V; Kilpi T
Vaccine; 2004 May; 22(15-16):2076-9. PubMed ID: 15121327
[TBL] [Abstract][Full Text] [Related]
27. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
Amarasinghe A; Black S; Bonhoeffer J; Carvalho SM; Dodoo A; Eskola J; Larson H; Shin S; Olsson S; Balakrishnan MR; Bellah A; Lambach P; Maure C; Wood D; Zuber P; Akanmori B; Bravo P; Pombo M; Langar H; Pfeifer D; Guichard S; Diorditsa S; Hossain MS; Sato Y
Vaccine; 2013 Apr; 31 Suppl 2():B108-14. PubMed ID: 23598471
[TBL] [Abstract][Full Text] [Related]
28. Guidelines for reporting adverse events associated with vaccine products. Division of Immunization, Bureau of Infectious Diseases, Laboratory Center for Disease Control.
Can Commun Dis Rep; 2000 Feb; 26 Suppl 1():I-IV, 1-18. PubMed ID: 11055081
[No Abstract] [Full Text] [Related]
29. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
[TBL] [Abstract][Full Text] [Related]
30. The Vaccine Safety Datalink: a model for monitoring immunization safety.
Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
[TBL] [Abstract][Full Text] [Related]
31. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
[TBL] [Abstract][Full Text] [Related]
32. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
33. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
Chang S; Ball R; Braun MM
Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
[TBL] [Abstract][Full Text] [Related]
34. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
[TBL] [Abstract][Full Text] [Related]
35. Presenting the case for an immunization safety surveillance system.
Darwish AA
Bull World Health Organ; 2000; 78(2):216. PubMed ID: 10743287
[No Abstract] [Full Text] [Related]
36. [Adverse events after vaccination].
Nøkleby H; Bergsaker MA
Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2541-4. PubMed ID: 17028637
[TBL] [Abstract][Full Text] [Related]
37. [Postmarketing surveillance of secondary effects of vaccines].
Duclos P
Rev Epidemiol Sante Publique; 1994; 42(5):425-33. PubMed ID: 7973002
[TBL] [Abstract][Full Text] [Related]
38. Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.
Moore KM; Duddy A; Braun MM; Platt R; Brown JS
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1137-41. PubMed ID: 18763248
[TBL] [Abstract][Full Text] [Related]
39. The complicated task of monitoring vaccine safety.
Ellenberg SS; Chen RT
Public Health Rep; 1997; 112(1):10-20; discussion 21. PubMed ID: 9018282
[TBL] [Abstract][Full Text] [Related]
40. [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].
Labadie J; van Grootheest AC
Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2738-42. PubMed ID: 18225798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
